Derma Sciences (DSCI) Posts Wider than Expected Q4 Loss of 23c/Share
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Research and development: 76.27K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 76.27K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q4 EPS of ($0.23), $0.12 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $16.39 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
